The Department of Pharmacology and Pharmacy at The University of Hong Kong is a leading center for pharmaceutical sciences. It fosters cutting-edge research, education, and training in pharmacology, clinical pharmacy, and innovative drug development, with a strong translational focus on improving patient outcomes.

A major research strength lies in nanomedicine and advanced drug delivery systems, utilizing nanotechnology to enhance drug bioavailability, minimize off-target toxicity, and broaden the therapeutic window.

Our key research areas include:

• Bioavailability enhancement of poorly absorbed anti-cancer drugs
• Nucleic acids therapeutics (siRNA, mRNA, pDNA)
• Targeted radiotherapy
• Immunotherapy
• Crystal engineering for drug design
• Respiratory drug delivery
• Ocular drug delivery
• Photopharmacology
• Ocular drug delivery
• Stimuli-responsive prodrugs and nanomedicines

This multidisciplinary research integrates expertise across fields to translate nano-engineered solutions into superior therapeutics, diagnostics, and patient outcomes in oncology, immunotherapy, neurodegeneration, and beyond. The department's efforts align with global pharmaceutical innovation, emphasizing the development of safer, more effective, and personalized medicines.

Professor Aviva CHOW
Associate Professor

✉ asfchow@hku.hk